Severely burned patient to be flown to Queen Astrid Hospital in Brussels stiripesurse.ro - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stiripesurse.ro Daily Mail and Mail on Sunday newspapers.
2021-05-03 14:06:11 GMT2021-05-03 22:06:11(Beijing Time) Xinhua English
BRUSSELS, May 3 (Xinhua) A new vaccination center opened its doors on Monday at Queen Astrid Military Hospital in Brussels, the second largest in the Belgian capital after the Heysel conference center.
Young people aged 16 and 17 will be eligible to receive the COVID-19 vaccine there this summer. Details on the rollout for younger age groups are still being reviewed by the Vaccination Task Force, the Belgian newspaper De Morgen reported on Monday.
The Pfizer/BioNTech vaccine has been approved by the European Medicines Agency (EMA) for people aged 16 and above.
Between Dec. 28, 2020, and May 1, 2021, a total of 3,058,382 people in Belgium received their first vaccine dose. Of them, 829,376 have already been administered the second dose as well, the Sciensano public health institute said Monday.
Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit
Bacteriophages infecting bacteria (illustration) [Christoph Burgstedt/Science Photo Library/Getty Images]
The overuse of broad-spectrum antibiotics has led to the development of multi-resistant bacterial strains, rendering antibiotics useless in the treatment of many infectious diseases.
As bacteriophages have re-emerged in recent times and the potential of phage or phage-derived products being used in a clinical setting is beginning to be understood, there remain several unique challenges associated with this novel therapeutic agent. These challenges range from a developing regulatory landscape and the design of clinical trials to the up-scaling of manufacturing processes are just a few of the roadblocks holding back development.